Real‐life effectiveness and short‐term (16‐week) tolerance of guselkumab for psoriasis: a Belgian retrospective multicentre study
Farida Benhadou, P-D. Ghislain, Françoise Guiot, Fabienne Willaert, V. del Mármol, J. Lambert, Rani Soenen, Hugues Fierens, M. de la Brassinne
Abstract
Dear Editor, We read with great interest the multicenter and retrospective study of Fougerosse et al1 that investigated real-life effectiveness and tolerance of guselkumab at week 16 in the treatment of cutaneous psoriasis. In the same manner, we conducted the first multicenter study in Belgium aiming to investigate real-life effectiveness and tolerance of guselkumab at week 16 in the treatment of cutaneous psoriasis. [...]
Topics & Concepts
MedicineUniversity hospitalPsoriasisRetrospective cohort studyDermatologyFamily medicineSurgeryPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesAutoimmune Bullous Skin Diseases